BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 22503562)

  • 21. CD38-mediated Ca(2+) signaling contributes to glucagon-induced hepatic gluconeogenesis.
    Rah SY; Kim UH
    Sci Rep; 2015 Jun; 5():10741. PubMed ID: 26038839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1.
    Lu M; Wan M; Leavens KF; Chu Q; Monks BR; Fernandez S; Ahima RS; Ueki K; Kahn CR; Birnbaum MJ
    Nat Med; 2012 Feb; 18(3):388-95. PubMed ID: 22344295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice.
    Nerurkar PV; Nishioka A; Eck PO; Johns LM; Volper E; Nerurkar VR
    Br J Nutr; 2012 Jul; 108(2):218-228. PubMed ID: 22011624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.
    Zhang W; Patil S; Chauhan B; Guo S; Powell DR; Le J; Klotsas A; Matika R; Xiao X; Franks R; Heidenreich KA; Sajan MP; Farese RV; Stolz DB; Tso P; Koo SH; Montminy M; Unterman TG
    J Biol Chem; 2006 Apr; 281(15):10105-17. PubMed ID: 16492665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
    Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
    J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice.
    Tripathy S; Jump DB
    J Lipid Res; 2013 Jan; 54(1):71-84. PubMed ID: 23099444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping MKP-3/FOXO1 interaction and evaluating the effect on gluconeogenesis.
    Jiao P; Feng B; Xu H
    PLoS One; 2012; 7(7):e41168. PubMed ID: 22848439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PHD3 regulates glucose metabolism by suppressing stress-induced signalling and optimising gluconeogenesis and insulin signalling in hepatocytes.
    Yano H; Sakai M; Matsukawa T; Yagi T; Naganuma T; Mitsushima M; Iida S; Inaba Y; Inoue H; Unoki-Kubota H; Kaburagi Y; Asahara SI; Kido Y; Minami S; Kasuga M; Matsumoto M
    Sci Rep; 2018 Sep; 8(1):14290. PubMed ID: 30250231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of gluconeogenesis in primary hepatocytes by stromal cell-derived factor-1 (SDF-1) through a c-Src/Akt-dependent signaling pathway.
    Liu HY; Wen GB; Han J; Hong T; Zhuo D; Liu Z; Cao W
    J Biol Chem; 2008 Nov; 283(45):30642-9. PubMed ID: 18786922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
    Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
    Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.
    Sajan MP; Ivey RA; Lee MC; Farese RV
    J Lipid Res; 2015 Jan; 56(1):70-80. PubMed ID: 25395359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner.
    Choi D; Oh KJ; Han HS; Yoon YS; Jung CY; Kim ST; Koo SH
    Hepatology; 2012 Oct; 56(4):1546-56. PubMed ID: 22532369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure.
    Pan Q; Ai W; Chen Y; Kim DM; Shen Z; Yang W; Jiang W; Sun Y; Safe S; Guo S
    Diabetes; 2023 Sep; 72(9):1193-1206. PubMed ID: 37343276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. InsP3R-Ca(2+) signaling takes center stage in the hormonal regulation of hepatic gluconeogenesis.
    Matsumoto M
    Cell Res; 2012 Nov; 22(11):1530-2. PubMed ID: 22710799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
    Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
    Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes.
    Naïmi M; Gautier N; Chaussade C; Valverde AM; Accili D; Van Obberghen E
    Endocrinology; 2007 May; 148(5):2424-34. PubMed ID: 17303659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.
    Matsumoto M; Pocai A; Rossetti L; Depinho RA; Accili D
    Cell Metab; 2007 Sep; 6(3):208-16. PubMed ID: 17767907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GCN5L1 modulates cross-talk between mitochondria and cell signaling to regulate FoxO1 stability and gluconeogenesis.
    Wang L; Scott I; Zhu L; Wu K; Han K; Chen Y; Gucek M; Sack MN
    Nat Commun; 2017 Sep; 8(1):523. PubMed ID: 28900165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic Insulin Resistance Following Chronic Activation of the CREB Coactivator CRTC2.
    Hogan MF; Ravnskjaer K; Matsumura S; Huising MO; Hull RL; Kahn SE; Montminy M
    J Biol Chem; 2015 Oct; 290(43):25997-6006. PubMed ID: 26342077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.